Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc.

MD·NYSE

$21.84

+1.0%
HealthcareMedical - Care Facilities

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians. The company also provides maternal-fetal care services, including inpatient and office-based clinical care to expectant mothers and unborn babies through affiliated maternal-fetal medicine subspecialists, as well as obstetricians and other clinicians, including maternal-fetal nurse practitioners, certified nurse mid-wives, ultrasonographers, and genetic counselors. In addition, it offers pediatric cardiology care services comprising inpatient and office-based pediatric cardiology care of the fetus, infant, child, and adolescent patient with congenital heart defects and acquired heart disease, as well as adults with congenital heart defects through affiliated pediatric cardiologist subspecialists and other related clinical professionals; and specialized cardiac care to the fetus, neonatal and pediatric patients. Further, the company provides other pediatric subspecialty care services through pediatric subspecialists, such as pediatric intensivists, pediatric hospitalists, pediatric surgeons, and pediatric ophthalmologists, as well as pediatric ear, nose, and throat physicians; and support services in the areas of hospitals, primarily in the pediatric emergency rooms, labor and delivery areas, and nursery and pediatric departments. As of February 17, 2022, it operated a network of approximately 2,700 physicians. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

At a Glance

Live Snapshot
Market Cap$1.79B
EPS1.9400
P/E Ratio11.26
Earnings Date08/04/2026
9.67%
Return on Invested Capital
-352%
3Y+43.0%
5Y-315.0%
10Y+33.0%
19.10%
Return on Equity
-247%
3Y+157.0%
5Y-118.0%
10Y+62.0%
7.36%
Return on Assets
-260%
3Y+161.0%
5Y-131.0%
10Y+21.0%
Pediatrix Medical Group, Inc.

Pediatrix Medical Group, Inc. Management Team

MD · NYSE
MM

Ms. Mary Ann E. Moore J.D.

Chief Administrative Officer, Executive Vice President, General Counsel & Secretary

Compensation

$1,621,052

Born 1961(Age 65)
female
MM

Mr. Mark S. Ordan

Chief Executive Officer & Executive Chairman

Compensation

$980,000

Born 1959(Age 67)
male
MK

Ms. Kasandra H. Rossi

Executive Vice President, Treasurer & Chief Financial Officer

Compensation

$953,071

Born 1973(Age 53)
female
MM

Mr. Mike Ashford

President of South Central Division

male
MK

Mr. Kevin Pitzer

President of West Division

male
MJ

Mr. John C. Pepia

Senior Vice President & Chief Accounting Officer

Compensation

$931,198

Born 1963(Age 63)
male
MC

Ms. Cheryl M. VanPatten

Senior Vice President & Chief Information Officer

female
MD

Mr. Daniel Patrick Corcoran

Senior Vice President of Administration & Managed Care

male
MN

Ms. Nanette Sanders

Senior Vice President of Operations

female
MD

Ms. Debra McRoberts

Senior Vice President of People Services

female
md

Pediatrix Medical Group, Inc. Insider Positioning

MD · NYSE

During the last 12 months, insiders have sold $1.83M worth of MD shares, with no buying activity reported.

3 Months

Bought

0

0.00

Sold

36.0K

855.66K

Net Activity

-856K

-$856K

3-6 Months

Bought

0

0.00

Sold

23.0K

515.43K

Net Activity

-515K

-$515K

6-9 Months

Bought

0

0.00

Sold

20.5K

457.49K

Net Activity

-457K

-$457K

9-12 Months

Bought

0

0.00

Sold

0

0.00

Net Activity

+0

+$0

Top Buyers

No buying activity

Top Sellers

1
WSA

Weis Shirley A

Director

36.0K shares1 transactions

$856K

2
OMS

Ordan Mark S

Director, Officer: Chief Executive Officer

23.0K shares1 transactions

$515K

3
RMA

Rucker Michael A.

Director

10.5K shares1 transactions

$241K

4
LLA

Linynsky Laura A

Director

10.0K shares1 transactions

$217K

Insider Activity Analysis

Net Insider Sentiment

Bearish

Strong bearish signal with $1.83M net selling. Heavy insider selling may indicate concerns about valuation or near-term prospects.

Buy/Sell Ratio

0.00:1

Very poor ratio. Heavy selling with minimal buying suggests insiders may be concerned about valuation or outlook.

Recent Trend (3 Months)

$856K

Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.

Insider Participation

High Selling

4 insider sellers vs. 0 buyers. Widespread selling across multiple insiders may signal concerns.

Insider Activity Insight

Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.

SEC Filings

MD - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
DEF 14A

DEF 14A 2026

N/A

March 27, 2026
March 25, 2026
2026
DEF 14A

DEF 14A 2025

N/A

March 28, 2025
March 26, 2025
2025
DEF 14A

DEF 14A 2024

N/A

March 28, 2024
May 09, 2024
2024
DEF 14A

DEF 14A

N/A

March 31, 2023
March 31, 2023
 
DEF 14A

DEF 14A 2022

N/A

April 01, 2022
May 12, 2022
2022
DEF 14A

DEF 14A 2021

N/A

March 23, 2021
May 12, 2021
2021
DEF 14A

DEF 14A 2020

N/A

July 28, 2020
September 09, 2020
2020
DEF 14A

DEF 14A 2019

N/A

March 29, 2019
May 16, 2019
2019
DEF 14A

DEF 14A 2018

N/A

March 23, 2018
May 16, 2018
2018
DEF 14A

DEF 14A 2017

N/A

March 17, 2017
May 11, 2017
2017
Showing 1 to 10 of 31 filings